Literature DB >> 21794735

[Primary Sjögren's syndrome: Expression of NF-κB in minor salivary glands].

Liliana Villalon1, Marta Mamani, Felix E Romanini, Antonio Catalan Pellet, Alejandro Berra.   

Abstract

PURPOSE: To evaluate nuclear NF-κ B translocation in minor salivary glands (mSG) of human primary Sjögren Syndrome (pSS).
METHODS: Lip biopsies' mSG were done in 24 female patients with pSS from the Rheumatology Service of Rivadavia Hospital. Glands were stained with H&E and immunostained for NF-κ B. Specimens were classified according to the Chisholm and Masson score.
RESULTS: The biopsies (H&E staining) showed lymphoplasmocitic infiltrates, forming periacini and periductal focuses which number depending on the stage of the disease. In stages III and IV there was acini destruction and, in some cases, fibrosis. In the biopsies with a diagnosis of sialadenitis we observed interstitially-dispersed lymphoplasmocitic elements and also polimorphonuclear neutrophils. The lip biopsies' mSG of patients with clinical-serological diagnosis of pSS showed nuclear translocation of NF-κ B in lymphocytes of focal infiltrates and in the acini epithelium adjacent to the infiltrates. In distal acini and ductal structures from the infitrates we did not observe nuclear translocation. However, in SSp patients with sialadenitis interstitial lymphocytes with nuclear translocation were observed but neither in the acini or the ducts. SSp patients with normal glands did not show nuclear translocation of NF-κ B factor either in the acini or in the ducts.
CONCLUSIONS: These results allow us to infer the importance of lymphocyte-epithelium interaction on the activation of NF-κ B in human pSS.
Copyright © 2009 Elsevier España, S.L. All rights reserved.

Entities:  

Year:  2010        PMID: 21794735     DOI: 10.1016/j.reuma.2009.10.009

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  4 in total

1.  Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.

Authors:  Sreedevi Chinthamani; Olutayo Odusanwo; Nandini Mondal; Joel Nelson; Sriram Neelamegham; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

2.  Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren's syndrome.

Authors:  Yuepeng Jiang; Xiaoxuan Zhao; Jie Yu; Qiao Wang; Chengping Wen; Lin Huang
Journal:  BMC Complement Med Ther       Date:  2021-03-01

3.  Decoding the Mechanism of CheReCunJin Formula in Treating Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Xiaoyu Xu; Linshuang Wang; Qian Chen; Zikang Wang; Xun Pan; Xike Peng; Miao Wang; Dongfeng Wei; Yanping Li; Bin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

4.  Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis.

Authors:  Weiqian Chen; Jin Lin; Heng Cao; Danyi Xu; Bei Xu; Liqin Xu; Lihuan Yue; Chuanyin Sun; Guolin Wu; Wenbin Qian
Journal:  J Immunol Res       Date:  2015-08-26       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.